OTC Analgesic Additional Safety Labeling To Be Considered By NDAC

Possible new labeling requirements and other initiatives designed to ensure the safety of OTC analgesics will be considered by FDA's Nonprescription Drugs Advisory Committee at a Sept. 19-20 meeting in Silver Spring, Md